LifeMD, Inc. (LFMD)
Market Cap | 218.29M |
Revenue (ttm) | 193.06M |
Net Income (ttm) | -25.61M |
Shares Out | 43.31M |
EPS (ttm) | -0.65 |
PE Ratio | n/a |
Forward PE | 12.08 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 1,333,244 |
Open | 4.88 |
Previous Close | 4.90 |
Day's Range | 4.76 - 5.15 |
52-Week Range | 3.99 - 12.88 |
Beta | 1.42 |
Analysts | Strong Buy |
Price Target | 12.13 (+140.68%) |
Earnings Date | Nov 7, 2024 |
About LFMD
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair lo... [Read more]
Financial Performance
In 2023, LifeMD's revenue was $152.55 million, an increase of 28.15% compared to the previous year's $119.03 million. Losses were -$23.70 million, -51.27% less than in 2022.
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for LFMD stock is "Strong Buy." The 12-month stock price forecast is $12.13, which is an increase of 140.68% from the latest price.
News
Health care stocks jump on Trump's nominee for FDA head
CNBC's Angelica Peebles joins 'Fast Money' to talk president-elect Trump's pick for FDA head.
LifeMD, Inc. (LFMD) Q3 2024 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Justin Schreiber – Chairman and Chief Executive Officer Marc Benathen – Chief Financial Of...
LifeMD Reports Third Quarter 2024 Results
Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65% Record gross margin of 90.6%, up 300 basis points from the year-ago period Adjusted EBITDA increased 33% to ...
LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividen...
LifeMD: Selling WorkSimpli Could Be A Catalyst
LifeMD's Q2 2024 earnings were mixed, with management failing to monetize the non-core WorkSimpli asset, leading me to assign it no value. Despite management's over-promising, LifeMD's telehealth and ...
LifeMD to Participate in Three Investor Conferences During September
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following inv...
LifeMD, Inc. (LFMD) Q2 2024 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD) Q2 2024 Earnings Conference Call August 7, 2024 4:30 PM ET Company Participants Justin Schreiber – Chairman and Chief Executive Officer Marc Benathen – Chief Financial Offi...
LifeMD Reports Second Quarter 2024 Results
Revenue increased 41% year-over-year to $50.7 million with telehealth revenue up 67% Telehealth achieved standalone profitability one quarter ahead of guidance, with adjusted EBITDA of $820,000 Weight...
LifeMD: High Growth GLP-1 Telehealth Play At A Discount
LifeMD is positioned as a high-growth telehealth play with a focus on GLP-1 weight management treatments. The company is guiding for 35% revenue growth in 2024. Its core telehealth business is expecte...
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash di...
LifeMD: Pairing GLP-1 Agonists With Virtual Healthcare
Identifying investment opportunities in the healthcare sector involves research on trends and next-gen tech. LifeMD offers telehealth services and weight management programs, positioned for growth in ...
LifeMD to Participate in the Truist Securities Healthcare Disruptors & Digital Health Summit
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the Truist Securities H...
LifeMD, Inc. (LFMD) Q1 2024 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Justin Schreiber - Chairman & Chief Executive Officer Marc Benathen - Chief Financial Officer C...
LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition
LifeMD and Withings Health Solutions partnership exemplifies the potential of digital health technology to transform virtual patient care and improve outcomes LifeMD and Withings Health Solutions part...
LifeMD Appoints Dr. Calum MacRae to its Board of Directors
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the appointment of Calum MacRae, M.D., Ph.D., a clinician...
LifeMD to Report First Quarter 2024 Financial Results on May 8
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ende...
LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the 23rd Annual Needha...
LifeMD: Results And Guidance Point To Continued Strength In Weight Management Program
LifeMD reported impressive revenue growth, with a 60% increase to $44.9 million, driven by a 90% increase in telehealth revenues. Weight management subscribers more than doubled sequentially, resultin...
LifeMD, Inc. (LFMD) Q4 2023 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD) Q4 2023 Earnings Conference Call March 11, 2024 4:30 PM ET Company Participants Justin Schreiber - Chairman and CEO Marc Benathen - CFO Conference Call Participants David L...
LifeMD Reports Fourth Quarter 2023 Results
Fourth quarter revenue increased 60% year-over-year to $44.9 million with Telehealth revenues increasing 90% versus the year-ago period. Adjusted EPS of $0.15 per share compared with $0.02 in the year...
LifeMD to Participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the 11th Annual BTIG MedTech, Digital Health, ...
LifeMD's 2024: Striking A Balance Between Rapid Expansion And Sustainability
LifeMD, Inc.'s newly issued 2024 guidance indicates an impressive 38% CAGR, positioning it as an attractive investment opportunity. With a valuation priced at less than 11x forward EBITDA, LifeMD stoc...
LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the Maxim Group 2024 Healthcare IT Virtual Con...
LifeMD: A GLP-1 Play With A Kicker
LifeMD expects a 38% increase in revenues for 2024, driven by its new telehealth operation for GLP-1 obesity drugs. Despite this, the stock is down significantly due to concerns over Eli Lilly direct ...
LifeMD: Medifast Partnership Further Validates Weight Management Program
Medifast partners with LifeMD to offer virtual weight management program with access to GLP-1 drugs. Medifast invests $20 million in LifeMD, with $10 million represented by common stock purchase. Surv...